SEO URLwww.firestrike.ai/deals/alnylam-pharmaceuticals-krilogy-acquisition-2026
acquisitionAnnounced · Feb 12, 2026biopharmaceuticalSource · CredibleArticle · Factual
Krilogy acquires Alnylam Pharmaceuticals
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.7M
Target
Alnylam Pharmaceuticals
NASDAQ: ALNY · Cambridge, Massachusetts
Acquirer
Krilogy
Financial Stake
Status
Completed
Krilogy agreed to acquire Alnylam Pharmaceuticals. Reported deal value: $1.7M. Status: Completed. Sector: biopharmaceutical. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-12. Figures and status may change as filings and press coverage update.
Krilogy Financial LLC Acquires New Stake in Alnylam Pharmaceuticals , Inc. $ALNY
Deal timeline
Announced
Feb 12, 2026 · marketbeat.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $1.7M. Figures and status may change as sources update.
Sources: marketbeat.com · Primary article · FireStrike proprietary index